167 related articles for article (PubMed ID: 28560426)
1. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.
Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X
Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426
[TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
Lin WW; Hsieh SL
Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
[TBL] [Abstract][Full Text] [Related]
3. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
[TBL] [Abstract][Full Text] [Related]
4. Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3.
Liu W; Ramagopal U; Cheng H; Bonanno JB; Toro R; Bhosle R; Zhan C; Almo SC
Structure; 2016 Nov; 24(11):2016-2023. PubMed ID: 27806260
[TBL] [Abstract][Full Text] [Related]
5. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.
Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP
Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030
[TBL] [Abstract][Full Text] [Related]
6. Decoy strategies: the structure of TL1A:DcR3 complex.
Zhan C; Patskovsky Y; Yan Q; Li Z; Ramagopal U; Cheng H; Brenowitz M; Hui X; Nathenson SG; Almo SC
Structure; 2011 Feb; 19(2):162-71. PubMed ID: 21300286
[TBL] [Abstract][Full Text] [Related]
7. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
Hsieh SL; Lin WW
J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
[TBL] [Abstract][Full Text] [Related]
8. EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis.
Wu NL; Huang DY; Hsieh SL; Hsiao CH; Lee TA; Lin WW
Biochim Biophys Acta; 2013 Oct; 1832(10):1538-48. PubMed ID: 23707413
[TBL] [Abstract][Full Text] [Related]
9. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.
Takahashi M; Miura Y; Hayashi S; Tateishi K; Fukuda K; Kurosaka M
Int J Mol Med; 2011 Sep; 28(3):423-7. PubMed ID: 21537832
[TBL] [Abstract][Full Text] [Related]
10. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
11. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.
Xiu Z; Shen H; Tian Y; Xia L; Lu J
Cytokine; 2015 Apr; 72(2):185-9. PubMed ID: 25647275
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B X protein upregulates decoy receptor 3 expression via the PI3K/NF-κB pathway.
Liang DY; Sha S; Yi Q; Shi J; Chen Y; Hou Y; Chang Q
Cell Signal; 2019 Oct; 62():109346. PubMed ID: 31229617
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
[TBL] [Abstract][Full Text] [Related]
14. The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.
Siakavellas SI; Sfikakis PP; Bamias G
Semin Arthritis Rheum; 2015 Aug; 45(1):1-8. PubMed ID: 25887448
[TBL] [Abstract][Full Text] [Related]
15. TNFSF/TNFRSF cytokine gene expression in sickle cell anemia: Up-regulated TNF-like cytokine 1A (TL1A) and its decoy receptor (DcR3) in peripheral blood mononuclear cells and plasma.
Safaya S; Alfarhan M; Sulaiman A; Alsulaiman A; Al-Ali A
Cytokine; 2019 Nov; 123():154744. PubMed ID: 31255916
[TBL] [Abstract][Full Text] [Related]
16. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action.
Yang CR; Hsieh SL; Teng CM; Ho FM; Su WL; Lin WW
Cancer Res; 2004 Feb; 64(3):1122-9. PubMed ID: 14871847
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
Im J; Kim K; Hergert P; Nho RS
J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
Shen HW; Gao SL; Wu YL; Peng SY
World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
[TBL] [Abstract][Full Text] [Related]
19. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
Siakavellas SI; Bamias G
Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
[TBL] [Abstract][Full Text] [Related]
20. Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT.
Wroblewski VJ; Witcher DR; Becker GW; Davis KA; Dou S; Micanovic R; Newton CM; Noblitt TW; Richardson JM; Song HY; Hale JE
Biochem Pharmacol; 2003 Feb; 65(4):657-67. PubMed ID: 12566095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
